Encompass Health Corporation

EHC Healthcare Medical Care Facilities

Encompass Health Corporation’s revenue for fiscal 2025 (year ended December 2025) was $5.9 billion, up 10.5% from fiscal 2024.

Revenue
+8.93%
EPS
+20.6%
Free cash flow
+52.3%
Total debt
+6.83%

Quarter to September 2026, against a year earlier

137.46 3.81 −2.70%
Market cap
$13.9B
P/E
21.2×
Fwd P/E
20.9×
Dividend yield
0.57%
F-score
7/9
Altman Z
3.25
Beneish M
−2.71
Dividend safety
77/100

Encompass Health Corporation (EHC) EV/Sales

Alert me on EV/Sales

As of 6 November 2026, Encompass Health Corporation (EHC) trades at a EV/Sales of 2.5×. Over the past ten years it has ranged from 1.5× (March 2020) to 2.8× (January 2021); the current reading is higher than 92% of that period. That is above the Medical Care Facilities industry median of 1.4× and below the Healthcare sector median of 3.5×.

EV/Sales, daily

Embed this chart

Annual newest first

Period EV/Sales Change
FY2025 2.2× 1.89%
FY2024 2.2× 11.57%
FY2023 1.9× (2.29%)
FY2022 2.0× (4.54%)
FY2021 2.1× (22.24%)
FY2020 2.7× 47.41%
FY2019 1.8× 7.32%
FY2018 1.7× 4.64%
FY2017 1.6× (0.10%)
FY2016 1.6× (9.26%)

Quarterly newest first

Period EV/Sales Change
Sep 2026 2.3× 13.24%
Jun 2026 2.0× 1.67%
Mar 2026 2.0× (10.02%)
Dec 2025 2.2× (15.60%)
43 more quarters

Against its own ten years

Low 1.5× High 2.8×
Ten-year median 2.0×
Current reading's percentile 93

EV/Sales against peers

What EV/Sales is

EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)

The full definition of EV/Sales →

More on EHC